Objectives: To evaluate relations of asymmetric dimethylarginine (ADMA) and nitric oxide (NO) with estrogen (E 2 ) and progesterone (Pg) and its role in pathogenesis and severity of pre- significantly lower E 2 and NO levels in PE women than women free of PE and in early than in late PE. High SBP at time of PE diagnosis showed positive significant correlation with body mass index (BMI) and serum ADMA levels but showed negative significant correlation with serum NO and E 2 levels. Serum ADMA levels showed positive significant correlation with BMI, but negative significant correlation with serum E 2 levels. High UAPI, serum ADMA and high BMI were significant early predictors for PE development and severity. Conclusion: Disturbed maternal serum ADMA/NO axis and low E 2 serum levels may underlie PE development. High BMI and low E 2 level may have a role in PE pathogenesis through induction of high serum ADMA levels. High UAPI and serum ADMA at 12 th week GA could be used as early predictors of PE especially early-onset and severe PE. Bull. of Egyp. Soc. Physiol. Sci.
Introduction
Pregnancy is marked by cardiovascular changes and adaptations involving vasodilation, angiogenic or remodeling. These adaptations are important for the maintenance and growth of the placenta and fetus. Estrogen is partially responsible for facilitating this dramatic increase in uterine blood flow during pregnancy (1) .
Uterine arteries from non-pregnant women respond to nitric oxide (NO) liberated from the endothelium and nitrergic nerves with relaxations.
Endothelial NO liberation is influenced by the phase of the estrous cycle, with its enhanced release at the follicular phase when the estrogen level is high (2) .
Placental vascular tone is critically influenced by NO derived from endothelial NO synthase (eNOS) activity (3) . NO bioavailability in the uteroplacental circulatory system is gradually increased during pregnancy (2) ADMA as a competitive endogenous inhibitor of NOS, thus elevated levels of ADMA may play a key role in the pathophysiology of endothelial dysfunction, in the progression of atherosclerosis and in cardiovascular diseases (7) . Although NO synthesis, as well as generation of ADMA, symmetric DMA and the arginine homolog homoarginine, occurs intracellularly, these biomarkers are usually measured in plasma (8) .
The study aimed to evaluate the relations of ADMA and NO with estrogen (E2) and progesterone (Pg) and its role played in the pathogenesis and severity of pre-eclampsia (PE).
Patients & Methods
The 
Statistical analysis
Sample size was calculated using the standard nomogram proposed by Kraemer & Thiemann (17) and a sample size of 30 patients was determined to be sufficient to detect a difference at the 5% significance level and give the trial 60%
power (18 
Discussion
The current study detected significantly higher maternal uterine artery pulsatility index (UAPI) and serum ADMA levels with significantly lower E2 and NO levels estimated in women who developed PE compared to women free of PE and in early than in late PE. Moreover, disturbed serum levels of studied parameters showed significant correlation with possibility of development and severity of PE.
In line with these findings, Alpoim et al. (19) (21) documented that logistic regression and ROC curve identified first-trimester placental growth factor (PGF) and ADMA to be sensitive and selective predictors of PE. Also, López-Alarcón et al. (24) reported gradually increased ADMA levels throughout pregnancy in PE and concluded that increased ADMA levels precede clinical manifestations of PE. 
Conclusion:
Disturbed maternal serum ADMA/NO axis and low E 2 serum levels may underlie development of PE. 
